제이엘케이

322510KOSDAQ

49.0 / 100

Reference Date: 2026-09-08

Financial Score15.0 / 40

News Sentiment21.0 / 25

Momentum3.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 14.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

JLK is a medical AI solution provider specializing in AI-based analysis of medical imaging, with a focus on stroke diagnosis and prognosis prediction. The company holds 78 global certifications and offers products such as MEDIHUB STROKE and cancer analysis solutions, driving growth in both domestic and international markets.

Number of Employees

87people

Average Salary

88.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

2.89Industry Average 1.200.0Point

2.4x industry avg (risky)

ROE

-30.01Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

21.64Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20253.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲45.6% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼40.9% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -41.9% (improving, 3yr)

Detailed News Sentiment

17 totalPositive 17Neutral 0Negative 0Average Sentiment Score 83.8

Positive
제이엘케이, 日 뇌졸중AI '인허가 다음은 매출'…7종 상용화 채널 구...
제이엘케이는 일본에서 뇌영상 AI 인허가를 넘어 상용화 매출 확대 전략을 추진하며 긍정적인 시장 반응을 얻고 있다.
Positive
제이엘케이 뇌졸중 AI 활용 연구, 美 심장협회 학술지 게재
제이엘케이의 뇌졸중 AI 연구가 국제 학술지에 게재되어 기술의 유효성과 혁신성을 인정받았다.
Positive
NIPA, 'AI 헬스 특별관'에 5000명 방문?도입·투자 협의 41...
NIPA's AI healthcare exhibition attracts over 5000 visitors, fostering significant engagement with healthcare and pharmaceutical sectors.

Detailed Momentum

52-week position1.0Point

Near 52w low (13%, downtrend)

Current 4,645Won52-week high 9,00052-week low 3,940

1-month return1.0Point

1m -14.77% (falling)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0

Neutral반기보고서 (2026.06)2026-08-14
Neutral독립이사의선임ㆍ해임또는중도퇴임에관한신고2026-08-14
Neutral임시주주총회결과2026-08-14